DE3173666D1 - Process for preparing immunoglobulin suitable for intravenous injection - Google Patents

Process for preparing immunoglobulin suitable for intravenous injection

Info

Publication number
DE3173666D1
DE3173666D1 DE8181109312T DE3173666T DE3173666D1 DE 3173666 D1 DE3173666 D1 DE 3173666D1 DE 8181109312 T DE8181109312 T DE 8181109312T DE 3173666 T DE3173666 T DE 3173666T DE 3173666 D1 DE3173666 D1 DE 3173666D1
Authority
DE
Germany
Prior art keywords
fraction
intravenous injection
iii
preparing immunoglobulin
immunoglobulin suitable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8181109312T
Other languages
English (en)
Inventor
Yahiro Uemura
Takashi Goto
Yoshiaki Kano
Satoshi Funakoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Application granted granted Critical
Publication of DE3173666D1 publication Critical patent/DE3173666D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8181109312T 1981-10-29 1981-10-29 Process for preparing immunoglobulin suitable for intravenous injection Expired DE3173666D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP81109312A EP0078331B1 (de) 1981-10-29 1981-10-29 Verfahren zur Herstellung von intravenösem injizierbarem Immunoglobulin

Publications (1)

Publication Number Publication Date
DE3173666D1 true DE3173666D1 (en) 1986-03-13

Family

ID=8187984

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8181109312T Expired DE3173666D1 (en) 1981-10-29 1981-10-29 Process for preparing immunoglobulin suitable for intravenous injection

Country Status (4)

Country Link
EP (1) EP0078331B1 (de)
AT (1) ATE17654T1 (de)
DE (1) DE3173666D1 (de)
HK (1) HK95586A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58180433A (ja) * 1982-04-16 1983-10-21 Fujirebio Inc 免疫グロブリンから抗補体作用物質の除去法
US4835257A (en) * 1984-07-07 1989-05-30 Armour Pharma Gmbh Process for preparing gamma globulin suitable for intravenous administration using peg and a citrate buffer
EP0168506B2 (de) * 1984-07-07 1998-01-07 Armour Pharma GmbH Verfahren zur Herstellung von gamma-Globulin zur intravenösen Anwendung
GB201413227D0 (en) 2014-07-25 2014-09-10 Bioproducts Lab Ltd Process

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3597409A (en) * 1970-05-25 1971-08-03 American Cyanamid Co Process for recoverring immunoglobulin a and immunoglobulin m
US3763135A (en) * 1971-11-08 1973-10-02 Baxter Laboratories Inc Gamma globulin production from cohn fraction iii using polyethylene glycol
ZA738779B (en) * 1972-11-27 1974-10-30 Baxter Laboratories Inc Production of gamma globulin
DE2364792A1 (de) * 1973-01-15 1974-07-18 South African Inventions Verfahren zum reinigen von gammaglobulin
US4000121A (en) * 1973-01-30 1976-12-28 Baxter Travenol Laboratories, Inc. Production of antisera comprising fractionating plasma or serum with an ethylene oxide-polyoxypropylene block copolymer
US3808189A (en) * 1973-03-15 1974-04-30 American Cyanamid Co Isolation of gamma globulin preparations enriched in iga and igm using polyethylene glycol
US4164495A (en) * 1976-04-06 1979-08-14 Nordisk Insulinlaboratorium Method of recovering immunoglobulin using a polyol and an alkanoic acid
US4165370A (en) * 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin

Also Published As

Publication number Publication date
HK95586A (en) 1986-12-19
EP0078331A1 (de) 1983-05-11
ATE17654T1 (de) 1986-02-15
EP0078331B1 (de) 1986-01-29

Similar Documents

Publication Publication Date Title
ES8106542A1 (es) Un procedimiento para la preparacion de un copolimero.
ATE16567T1 (de) Intravenoes injektierbares globulin aus immunserum und verfahren zu seiner herstellung.
ATE88097T1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
ES8502461A1 (es) Procedimiento de obtencion de composiciones de polimeros termoplasticos reforzadas con fibra
ATE45382T1 (de) Biosynthetisch hergestellter humannervenwachstumsfaktor, verfahren zu seiner herstellung, diesen faktor enthaltende zusammensetzungen, diesen faktor codierende dna- sequenz, vektoren, die diese sequenz enthalten und dadurch transformierte wirtszellen.
DK0447585T3 (da) Fremgangsmåde til fremstilling af et intravenøst tolerant immunglobulin-G-præparat
DE68920234D1 (de) Verfahren zur Herstellung eines oxidischen Supraleiters.
ATE162205T1 (de) Verfahren zur herstellung von polysuccinimidpolymeren
DE3788229D1 (de) Verfahren zur isolierung von ca 125-antigen.
EP0246579A3 (en) Method of producing immunoglobulin preparations for intravenous injection
HU911662D0 (en) Process for manufacturing stable bitumen and polymer mixtures
GB1126915A (en) A method of after-treating fibre- and film-forming polyesters
DE3687216D1 (de) Verfahren zur entgasung von verschmolzenem polymethylenoxid.
DE3173666D1 (en) Process for preparing immunoglobulin suitable for intravenous injection
ES8304431A1 (es) "un metodo para preparar una inmunoglobulina adecuada para administracion intravenosa".
ATE82579T1 (de) Verfahren zur herstellung von copolymerisaten aus maleinsaeuremonoalkylestern und vinylalkylethern.
DE68907735D1 (de) Genfragmente, die die variable region eines anti-hiv-antikoerpers codieren, von diesen exprimierte chimaere anti-hiv-antikoerper und verfahren zu deren herstellung.
DE50007078D1 (de) Copolymere mit amphiphilen untereinheiten, verfahren zu deren herstellung und deren verwendung
GB845688A (en) A method of treating polyethylene glycol terephthalate filaments or fibres in order to facilitate subsequent processing of the filaments or fibres, for example on a card
CA2087987A1 (en) A method for the treatment of wool
ATE111135T1 (de) Verfahren zur herstellung von mit nichtfaserigen kohlehydraten gefüllten ethylen-copolymeren und ihre verwendung.
DE3750348D1 (de) Verfahren zur Herstellung von Peptiden, dazu zu verwendendes rekombinantes Plasmid und mit diesem Plasmid transformierte Myelomzellen.
EP0258111A3 (de) Neuronotrophischer Faktor
EP0148025A3 (en) Antibodies and antibody-containing compositions for inhibiting periodontitis
JPS5732228A (en) Preparation of immunoglobulin usable for intravenous injection

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee